000 | 01555 a2200373 4500 | ||
---|---|---|---|
005 | 20250516101942.0 | ||
264 | 0 | _c20130225 | |
008 | 201302s 0 0 chi d | ||
022 | _a0253-3766 | ||
024 | 7 |
_a10.3760/cma.j.issn.0253-3766.2012.02.018 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aXu, Jian-Ming | |
245 | 0 | 0 |
_a[More attention should be paid to the understanding of gastroenteropancreatic neuroendocrine tumors]. _h[electronic resource] |
260 |
_bZhonghua zhong liu za zhi [Chinese journal of oncology] _cFeb 2012 |
||
300 |
_a158-60 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
650 | 0 | 4 | _aBevacizumab |
650 | 0 | 4 |
_aGastrointestinal Neoplasms _xclassification |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aIndoles _xtherapeutic use |
650 | 0 | 4 |
_aNeuroendocrine Tumors _xclassification |
650 | 0 | 4 |
_aOctreotide _xtherapeutic use |
650 | 0 | 4 |
_aPancreatic Neoplasms _xclassification |
650 | 0 | 4 |
_aPeptides, Cyclic _xtherapeutic use |
650 | 0 | 4 |
_aPyrroles _xtherapeutic use |
650 | 0 | 4 |
_aSirolimus _xanalogs & derivatives |
650 | 0 | 4 |
_aSomatostatin _xanalogs & derivatives |
650 | 0 | 4 | _aSunitinib |
773 | 0 |
_tZhonghua zhong liu za zhi [Chinese journal of oncology] _gvol. 34 _gno. 2 _gp. 158-60 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.3760/cma.j.issn.0253-3766.2012.02.018 _zAvailable from publisher's website |
999 |
_c21932761 _d21932761 |